Role of electroconvulsive therapy in neuroleptic malignant syndrome (NMS)

[1]  J. Haggerty,et al.  Neuroleptic Malignant Syndrome Superimposed on Tardive Dyskinesia , 1987, British Journal of Psychiatry.

[2]  A. L. George,et al.  Succinylcholine-induced hyperkalemia complicating the neuroleptic malignant syndrome. , 1987, Annals of internal medicine.

[3]  J. Hughes.  ECT during and after the neuroleptic malignant syndrome: case report. , 1986, The Journal of clinical psychiatry.

[4]  A. Shalev,et al.  The Aftercare of the Patient with the Neuroleptic Malignant Syndrome , 1985, British Journal of Psychiatry.

[5]  B. Liskow.  Relationship between neuroleptic malignant syndrome and malignant hyperthermia. , 1985, The American journal of psychiatry.

[6]  K. Gujavarty,et al.  The neuroleptic malignant syndrome: review and report of three cases. , 1985, Comprehensive psychiatry.

[7]  D. Westenskow,et al.  CO2PRODUCTION (VC O2) RELATED TO ANESTHETIC DEPTH , 1984 .

[8]  I. Azar.  The Response of Patients with Neuromuscular Disorders to Muscle Relaxants: A Review , 1984, Anesthesiology.

[9]  P. White.  Treatment of Neuroleptic Malignant Syndrome , 1984, British Journal of Psychiatry.

[10]  G. F. Anderson,et al.  ECT in the neuroleptic malignant syndrome: case report. , 1983, The Journal of clinical psychiatry.

[11]  J. Delacour,et al.  TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME WITH DANTROLENE , 1982, The Lancet.

[12]  J. G. Goekoop,et al.  TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME WITH DANTROLENE , 1982, The Lancet.

[13]  J. Alpert,et al.  Sudden catatonic stupor with disastrous outcome. , 1977, JAMA.